image credit- shutterstock
DCDC Health Services, which operates dialysis centres under the DCDC Kidney Care brand, has secured a significant investment of Rs 150 crore from Singapore-based ABC Impact, the Asia-focused impact investor backed by Temasek.
Founded in 2009, DCDC operates more than 200 centres across India and is one of the foremost operators of dialysis clinics, both under public-private partnerships (PPP) and company-owned standalone clinics.
The investment from ABC Impact will support Delhi-based DCDC’s expansion plans, facilitating the rollout of over 150 new clinics across the country in the coming months. On average, patients in India must travel up to 50 kilometres to access a dialysis centre. This expansion will help address the growing need for accessible, affordable dialysis services for those with ESRD inline with the Ayushman Bharat Yojna.
It is estimated that over 1.5 million people in India are living with end-stage renal disease and require dialysis three times a week. However, many face barriers to access due to high treatment costs, a lack of available facilities, and inconsistent quality of care. These challenges disproportionately affect low-income families, who often struggle to afford the cost of treatment or are forced to stop treatment altogether.
Aseem Garg, Founder and CEO of DCDC, said, “This investment from ABC Impact will help enhance our efforts to transform kidney care in India. With this investment, we plan to expand our network of company-owned centers, ensuring last-mile connectivity and making high-quality dialysis care accessible closer to patients’ homes. We also plan to address this challenge and extend our solutions to countries beyond India”
Sugandhi Matta, Chief Impact Officer, ABC Impact, said, "With the growing burden of kidney disease in India, increasing access to quality dialysis is both a healthcare and economic necessity. DCDC’s proven model of expanding affordable dialysis services aligns with our commitment to improving healthcare outcomes while ensuring long-term sustainability. By supporting DCDC’s growth, we aim to help more patients receive life-saving treatment closer to home, reducing the financial and logistical barriers they currently face."
DCDC counts IFU, a Danish government owned investment fund and ADB (Asian Development Bank) among its existing shareholders. IFU’s investment is made through the Danish SDG Investment Fund, which is backed by the Danish State, large Danish pension funds and other private and institutional investors.
